- PCI-34051
-
- $55.00 / 5mg
-
2026-04-22
- CAS:950762-95-5
- Min. Order:
- Purity: 97.21%
- Supply Ability: 10g
|
| | PCI 34051 Basic information |
| | PCI 34051 Chemical Properties |
| density | 1.25 | | storage temp. | Sealed in dry,Store in freezer, under -20°C | | solubility | insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL in DMSO | | pka | 9.16±0.30(Predicted) | | form | Powder | | color | White to gray | | InChI | InChI=1S/C17H16N2O3/c1-22-15-6-2-12(3-7-15)11-19-9-8-13-4-5-14(10-16(13)19)17(20)18-21/h2-10,21H,11H2,1H3,(H,18,20) | | InChIKey | AJRGHIGYPXNABY-UHFFFAOYSA-N | | SMILES | N1(CC2=CC=C(OC)C=C2)C2=C(C=CC(C(NO)=O)=C2)C=C1 |
| Hazard Codes | Xn | | Risk Statements | 22-36 | | Safety Statements | 26 |
| | PCI 34051 Usage And Synthesis |
| Uses | PCI-34051 is a potent, histone deacetylase 8 (HDAC8)-specific inhibitor. PCI-34051 induces caspase-dependent apoptosis in cell lines derived from T-cell lymphomas or leukemias. PCI-34051 did not affect other hematopoietic or solid tumor lines. PCI-34051 treatment has been shown to significantly reduce cholesterol accumulation in Niemann-Pick type C1 gene mutated human fibroblast. | | Definition | ChEBI: N-hydroxy-1-[(4-methoxyphenyl)methyl]-6-indolecarboxamide is an indolecarboxamide. | | Biological Activity | pci-34051 is a potent, specific inhibitor of histone deacetylase 8 (hdac8) with greater than 200-fold selectivity over the other hdac isoforms, such as 1, 2, 3, 6 and 10. it induces caspase dependent apoptosis in cell lines derived from t-cell lymphomas or leukemias, but not in other hematopoietic or solid tumor lines. pci-34051 does not cause detectable histone or tubulin acetylation and also does not inhibit growth or induce apoptosis in normal cells such as pbmcs or fibroblasts. although a phospholipase c-gamma1 (plcgamma1) defective line is resistant, cells defective in t-cell receptor signaling are still sensitive to pci-34051 induced apoptosis. | | in vivo | Administration of PCI-34051 and Dexamethasone reduces the eosinophilic inflammation and airway hyperresponsiveness in asthma to reduce the airway remodeling[2]. | | IC 50 | HDAC8: 10 nM (IC50); HDAC6: 2.9 μM (IC50); HDAC1: 4 μM (IC50); HDAC10: 13 μM (IC50) | | storage | -20°C |
| | PCI 34051 Preparation Products And Raw materials |
|